semaglutide weight loss brain cells connected to nerve in the brain, study finds Ozempic and other GLP-1 drugs

The company has become the first Indian pharmaceutical firm to receive approval from the Drugs Controller General of India (DCGI) for a generic version of semaglutide

First, administration is once weekly the same day every week never daily

or a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke

Acute and sustained GLP-1 receptor signalling leads to reduction in appetite and food intake leading to subsequent weight loss [14, 15]

Similar findings have been found with the other aromatase inhibitors (i.e., exemestane and letrozole) when compared to tamoxifen in postmenopausal women with early breast cancer